Search company, investor...

Founded Year

2010

Stage

IPO | IPO

Date of IPO

10/15/2021

Market Cap

0.88B

Stock Price

10.63

About Paragon28

Paragon28 focuses on the medical device industry, specifically in foot and ankle treatments. The company offers a range of products including plating systems, screw systems, implants, and biologics, all designed to aid in the treatment of various foot and ankle conditions. The primary customers of Paragon28 are likely to be healthcare providers and professionals in the medical industry. It was founded in 2010 and is based in Englewood, Colorado.

Headquarters Location

14445 Grasslands Dr.

Englewood, Colorado, 80112,

United States

855-786-2828

Loading...

Loading...

Latest Paragon28 News

Paragon 28 Launches BEAST Cortical Fibers Expanding its Biologics Portfolio

Nov 15, 2023

Paragon 28 Launches BEAST Cortical Fibers Expanding its Biologics Portfolio These loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon hydration allowing for application even in extremely challenging fusion locations BEAST Cortical Fibers. (Credit: Business Wire) Paragon 28 is pleased to announce the launch of its BEAST Cortical Fibers which provide an osteoinductive porous structure for cellular attachment and an osteoinductive potential to aid in cellular differentiation and bone formation. These loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon hydration allowing for application even in extremely challenging fusion locations. The cortical matrix absorbs bioactive fluid including bone marrow aspirate and supports cellular infiltration to drive efficient bone remodeling. Powerful processing capability allows for preservation of native bone morphologic proteins (BMPs) and other growth factors necessary for the promotion of bone formation. The addition of the BEAST Cortical Fibers bolsters Paragon 28’s biologics product offering, which includes the PRESERVE Bone Wedge System, V92 and V92-FC+ Cellular Bone Matrices, MgNum Bone Void Filler, Paraderm Dermal Matrix, BEAST Demineralized Bone Matrices, and Pro3 Placenta and Cord Regenerative Tissue Matrices. With this comprehensive portfolio, Paragon 28 provides its customers with innovative biologic solutions for reconstruction and trauma. Source: Company Press Release

Paragon28 Frequently Asked Questions (FAQ)

  • When was Paragon28 founded?

    Paragon28 was founded in 2010.

  • Where is Paragon28's headquarters?

    Paragon28's headquarters is located at 14445 Grasslands Dr., Englewood.

  • What is Paragon28's latest funding round?

    Paragon28's latest funding round is IPO.

  • Who are the investors of Paragon28?

    Investors of Paragon28 include Piper Sandler and MVM Partners.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.